Condition
Major Adverse Cardiovascular Event
Total Trials
4
Recruiting
3
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting3
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05578300Recruiting
Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific
NCT04992195Recruiting
Impact of COVID-19 Vaccines on Cerebrovascular Health
NCT06885619Active Not Recruiting
Prediction of LVAR and MACE in AMI Though Plasma Multiomics Analysis
NCT05378035Recruiting
DOAC in Chinese Patients With Atrial Fibrillation
Showing all 4 trials